NRx Pharmaceuticals signs U.S. patent agreement related to NRX-10 for chronic pain August 7, 2023 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Viatris Inc nd Mapi Pharma Announce FDA Acceptance of NDA Filing for GA Depot for the Treatment of Relapsing Forms of Multiple Sclerosis Back: All Posts Next:BMO Capital maintains Alliant Energy at 'outperform' with a price target of $58.00